本页面由Tiger Trade Technology Pte. Ltd.提供服务

Immunovant, Inc.

39.41
+0.04000.10%
盘后39.410.00000.00%19:34 EDT
成交量:72.71万
成交额:2,862.00万
市值:80.91亿
市盈率:-14.22
高:39.87
开:39.80
低:38.70
收:39.37
52周最高:41.23
52周最低:14.32
股本:2.05亿
流通股本:7,983.12万
量比:0.82
换手率:0.91%
股息:- -
股息率:- -
每股收益(TTM):-2.7716
每股收益(LYR):-2.7716
净资产收益率:-64.82%
总资产收益率:-38.43%
市净率:9.49
市盈率(LYR):-14.22

数据加载中...

2026/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/20

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/05/20

重要事件披露

Form 8-K - Current report
2026/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/02/06

重要事件披露

Form 8-K - Current report
2025/12/12

重要事件披露

Form 8-K - Current report
2025/12/11

重要事件披露

Form 8-K - Current report
2025/12/11

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2025/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities